Posted by West on January 25, 2010, at 7:32:16
In reply to Re: milancipran question: Bleauberry or anyone? » floatingbridge, posted by bleauberry on January 20, 2010, at 19:06:55
Milnacipran's tolerability can be an issue, there were obvious issues with headaches, orthostatic hypotension and tachycardia at the recommended theraputic dose 150mg as I recall.
This is probably why pierre-fabre/forst are trying to bring l-milnacipran to market. It's currently in stage II trials.
www.neurotransmitter.net/newdrugs.html
You might be able to manage ok on a smaller dose. The only way to find out is to try it I suppose. You could go half/half for a week with pristiq as long as there are no enzymatic interactions then 75/25 and see how it goes.
poster:West
thread:934250
URL: http://www.dr-bob.org/babble/20100122/msgs/934936.html